AANEM Advocacy News Express

AANEM News Express

2013 EDX Code Set Inappropriately Causing Insurance Denials

Have you been experiencing claims denials of EMG codes 95885-95887 when billed with the new nerve conduction study (NCS) codes 95907-95913?

Revised Medicare Fee Schedule Has Been Posted

On January 4, the revised 2013 Medicare fee schedule was posted on the Centers for Medicare and Medicaid Services website.

Medicare SGR and Sequestration Cuts Averted

Thanks to last minute votes by both the Senate and House of Representatives, Medicare physician reimbursement rates will remain at the 2012 level through 2013.

Coding Alert: Update on AANEM Meeting with CMS

Yesterday, representatives from AANEM, AAN, AAPMR, and APTA* traveled to Washington D.C. to meet with Jonathan Blum, director, Center for Medicare Management.

One Simple Step to Help Shape Health Care Policy

Don’t miss your opportunity to help shape health care policy. When renewing your AMA membership, be sure to indicate AANEM as your specialty society.

AANEM Sends Coalition Letter to Congress

On December 10, 2012, the AANEM and 98 other organizations concerned about the impact of the 2013 cuts to reimbursement for electrodiagnostic (EDX) procedures sent a coalition letter to Congressional leadership and committees.

Coding Update: Please Act Now

It’s time to act! We need you to contact your members of Congress today to tell them to protect the future of electrodiagnostic and neuromuscular medicine.

2013 Coding Changes Significantly Reduce EDX RVUs

CMS has announced the electrodiagnostic medicine relative value units for 2013. While most EMG RVUs have increased, the nerve conduction study RVUs have decreased significantly.

Reduction of RVUs for EMG and NCS Codes

The Centers for Medicare and Medicaid Services (CMS) has published its work and practice relative value units (RVUs) for 2013.

AANEM Endorses IVIg Guideline

The American Association of Neuromuscular & and Electrodiagnostic Medicine (AANEM) recently endorsed the American Academy of Neurology (AAN) guideline on IVIg.






Devon products